Company / Current Liabilities
AYTU BIOPHARMA, INC Current Liabilities History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$63.1M
FY2025
5-year range
$62.2M / $109.4M
FY2021-FY2025
Trend
+1.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 10 years, ranging from $1M in FY2015 to $109M in FY2021.
Based on SEC 10-K filings.
$63M in FY2025 with a 10-year CAGR of +45.6%.
Improved from $69M to $63M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -0.7%
- 5-Year CAGR
- +17.0%
- 10-Year CAGR
- +45.6%
Key checks
Key Insights
- 5-year CAGR of +17.0%, indicating consistent growth.
- In FY2025, current liabilities increased 1.3% year-over-year.
- Peak current liabilities was recorded in FY2021.
- Lowest current liabilities in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $63.1M | +1.3% |
| FY2024 | $62.2M | -9.8% |
| FY2023 | $69.0M | +7.1% |
| FY2022 | $64.4M | -41.1% |
| FY2021 | $109.4M | +280.5% |
| FY2020 | $28.8M | +747.3% |
| FY2018 | $3.4M | -6.0% |
| FY2017 | $3.6M | -64.3% |
| FY2016 | $10.1M | +583.8% |
| FY2015 | $1.5M | +1126.0% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026